Under construction – not a live service
Sign in
Not yet taking people in FranceNo phase

Brain scan signs and outcomes in patients with brain bleeding

Studies whether scan signs predict death or disability in adults with brain bleeding.

Plain-language title generated from the registry record
Registry title: High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Markers

Key facts

Where
Gonesse, FranceSee the site

Where in France

  • Centre Hospitalier de GonesseGonesse, FranceNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centre Hospitalier de Gonesse
Trial code
NCT07172542
Record updated
15 September 2025
Original description
This study looks at patients with brain hemorrhage to see if a special sign on brain scans, called the "Spot Sign," combined with other scan features, can predict a higher risk of death or disability. By comparing patient outcomes with existing prediction scores, the study aims to understand whether these scan markers provide extra value in identifying patients at higher risk.Read full original descriptionShow less

High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Markers

This study looks at patients with brain hemorrhage to see if a special sign on brain scans, called the "Spot Sign," combined with other scan features, can predict a higher risk of death or disability. By comparing patient outcomes with existing prediction scores, the study aims to understand whether these scan markers provide extra value in identifying patients at higher risk.

Inclusion: Spontaneous intracerebral hemorrhage confirmed by contrast-enhanced CT scan; Follow-up CT scan performed within 24 to 48 hours; Non-inclusion Criteria :; Absence of initial contrast-enhanced CT or follow-up CT; Hematoma due to trauma, epidural hematoma (EDH), subdural hematoma (SDH), or subarachnoid hemorrhage (SAH).

Exclusion: Patient deceased before the initial contrast-enhanced CT; Major missing clinical data.

ClinicalTrials.gov NCT07172542